Severity: Warning
Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 197
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 197
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 271
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3145
Function: getPubMedXML
File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 316
Function: require_once
In the pharmaceutical industry, ongoing research and development focus on discovering new drug formulations that align with regulatory approvals. Recently, innovative drug delivery systems have been used to maximize therapeutic efficacy with a precision of sustained drug delivery in the disease management system. Nanocellulose (NCs) synthesized from abundant cellulose, have attracted wide attention for potential pharmaceutical applications due to their unique properties, such as biocompatibility, high surface area-to-volume ratio, extensive drug loading and binding capacity, controlled drug release efficiency, strength, and availability with various treatments and modification ability. Nevertheless, research on nanocarriers (NCs) in the pharmaceutical field faces several limitations and challenges. Key areas requiring further exploration include chemical consumption, energy intensity, effluent management, recovery processes from acid hydrolysis, reaction times, ecotoxicology, and overall development progress. This overview provides the applications of emerging nanocellulose. It gives a clue on the synthesis of sustainable NCs related to their different sources, pre- and post-modifications of NCs, and key properties in pharmaceutical sectors. Furthermore, it gives an overview of the current advancements, life cycle analysis, biosafety, and key property performance with a summary of challenges and future perspectives.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ijbiomac.2025.141427 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!